Keyphrases
Chimeric Antigen Receptor T Cells (CAR-T)
100%
T-cell Malignancies
100%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
75%
Targeted Therapy
50%
Remission
25%
Overexpression
25%
Hematological Malignancies
25%
T Cells
25%
U.S. Food
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
25%
B-cell Lymphoma
25%
Effective Therapy
25%
Cancer Immunotherapy
25%
Curative Treatment
25%
Novel Agents
25%
Complete Remission
25%
Heterogeneous Disease
25%
Associated Risk
25%
Relapse-free Survival
25%
Childhood Acute Lymphoblastic Leukemia
25%
B-cell Leukemia
25%
T-cell Markers
25%
Long-term Relapse
25%
Fratricide
25%
Medicine and Dentistry
Cancer
100%
T Cell
100%
Chimeric Antigen Receptor T-Cell
100%
Acute Lymphoblastic Leukemia
50%
Targeted Therapy
33%
Hematologic Malignancy
16%
Spontaneous Remission
16%
B-Cell Lymphoma
16%
Stem Cell Transplant
16%
Recurrence Free Survival
16%
Cancer Immunotherapy
16%
Cell Marker
16%
CD2 Antigen
16%
B Cell Leukemia
16%
Chimeric Antigen Receptor
16%
Leukemia in Children
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Antigen Receptor
100%
Acute Lymphoblastic Leukemia
100%
Remission
66%
Malignant Neoplasm
33%
Hematologic Malignancy
33%
Immunotherapy
33%
B Cell Lymphoma
33%
Recurrence Free Survival
33%
Cell Marker
33%
B Cell Leukemia
33%
CD2 Antigen
33%
Diseases
33%
Immunology and Microbiology
T Cell
100%
Chimeric Antigen Receptor T-Cell
100%
CD7
44%
B Cell
11%
Cancer Immunotherapy
11%
Stem Cell Transplant
11%
CD5
11%
Recurrence Free Survival
11%
Cell Marker
11%
CD2
11%
Chimeric Antigen Receptor
11%